Junlai Wan

418 total citations
17 papers, 273 citations indexed

About

Junlai Wan is a scholar working on Rheumatology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Junlai Wan has authored 17 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Rheumatology, 5 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Junlai Wan's work include Osteoarthritis Treatment and Mechanisms (10 papers), Extracellular vesicles in disease (3 papers) and Renal cell carcinoma treatment (2 papers). Junlai Wan is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (10 papers), Extracellular vesicles in disease (3 papers) and Renal cell carcinoma treatment (2 papers). Junlai Wan collaborates with scholars based in China, Sweden and Japan. Junlai Wan's co-authors include Anmin Chen, Zhiyi He, Peng Cheng, Xiaoxia Hao, Jiarui Cui, Jiaming Zhang, Xiaopei Wu, Renpeng Peng, Jiaqiao Zhang and Shaogang Wang and has published in prestigious journals such as Scientific Reports, Journal of Controlled Release and Carbohydrate Polymers.

In The Last Decade

Junlai Wan

17 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junlai Wan China 10 113 87 40 40 37 17 273
Fazal‐Ur‐Rehman Bhatti United States 10 88 0.8× 105 1.2× 34 0.8× 34 0.8× 17 0.5× 19 325
Jiangbo Nie China 9 70 0.6× 146 1.7× 18 0.5× 28 0.7× 29 0.8× 18 313
Zhixian Zong China 8 91 0.8× 178 2.0× 15 0.4× 31 0.8× 20 0.5× 10 331
Jiaji Yue China 11 85 0.8× 139 1.6× 29 0.7× 45 1.1× 18 0.5× 21 355
Guihua Tan China 10 153 1.4× 104 1.2× 11 0.3× 26 0.7× 19 0.5× 17 296
Xueman Zhou China 11 90 0.8× 163 1.9× 24 0.6× 51 1.3× 66 1.8× 31 431
Jian Mo China 11 43 0.4× 144 1.7× 48 1.2× 51 1.3× 24 0.6× 26 426
Seyyed Mehdi Jafari Iran 13 79 0.7× 192 2.2× 19 0.5× 41 1.0× 40 1.1× 35 448
Yaping Ma China 11 44 0.4× 149 1.7× 33 0.8× 106 2.6× 23 0.6× 24 416
Chunchun Xue China 10 41 0.4× 163 1.9× 19 0.5× 28 0.7× 23 0.6× 19 342

Countries citing papers authored by Junlai Wan

Since Specialization
Citations

This map shows the geographic impact of Junlai Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junlai Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junlai Wan more than expected).

Fields of papers citing papers by Junlai Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junlai Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junlai Wan. The network helps show where Junlai Wan may publish in the future.

Co-authorship network of co-authors of Junlai Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Junlai Wan. A scholar is included among the top collaborators of Junlai Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junlai Wan. Junlai Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Chen, Jiaoxiang, et al.. (2025). Conditional sequential delivery of ginkgetin and rapamycin orchestrates inflammation and autophagy to alleviate intervertebral disc degeneration. Journal of Controlled Release. 381. 113556–113556. 4 indexed citations
2.
Wang, Zhenggang, et al.. (2024). EphA2-specific microvesicles derived from tumor cells facilitate the targeted delivery of chemotherapeutic drugs for osteosarcoma therapy. Journal of Nanobiotechnology. 22(1). 89–89. 7 indexed citations
3.
Yuan, Xi, Long Huang, Meng Zheng, et al.. (2024). Hydroxypropyl chitin-oxidized chondroitin sulfate double-network hydrogel assists microfracture technique to enhance cartilage regeneration. Materials & Design. 238. 112656–112656. 12 indexed citations
4.
Wan, Junlai, et al.. (2023). Stevioside protects primary articular chondrocytes against IL-1β-induced inflammation and catabolism by targeting integrin. International Immunopharmacology. 119. 110261–110261. 6 indexed citations
5.
Wan, Junlai, Zhiyi He, Renpeng Peng, et al.. (2023). Injectable photocrosslinking spherical hydrogel-encapsulated targeting peptide-modified engineered exosomes for osteoarthritis therapy. Journal of Nanobiotechnology. 21(1). 284–284. 73 indexed citations
6.
Wan, Junlai, Zhiyi He, Yingchao Zhao, et al.. (2023). Novel strategy of senescence elimination via toxicity-exempted kinome perturbations by nanoliposome-based thermosensitive hydrogel for osteoarthritis therapy. Advanced Composites and Hybrid Materials. 6(3). 21 indexed citations
7.
Wu, Yipeng, et al.. (2023). MXenes-based photothermal hydrogels for macrophage polarization regulation via heat-shock protein. Journal of Materials Science. 58(48). 18133–18146. 5 indexed citations
8.
Wan, Junlai, Mengwei Li, Xi Yuan, et al.. (2023). Rutaecarpine ameliorates osteoarthritis by inhibiting PI3K/AKT/NF‑κB and MAPK signalling transduction through integrin αVβ3. International Journal of Molecular Medicine. 52(4). 13 indexed citations
9.
Wang, Zhenggang, Zhiyi He, Junlai Wan, et al.. (2023). Decreased Peli1 expression attenuates osteoarthritis by protecting chondrocytes and inhibiting M1-polarization of macrophages. Bone and Joint Research. 12(2). 121–132. 12 indexed citations
10.
Wan, Junlai, Tianqi Wang, Zhiyi He, et al.. (2022). Flavokawain A alleviates the progression of mouse osteoarthritis: An in vitro and in vivo study. Frontiers in Bioengineering and Biotechnology. 10. 1071776–1071776. 2 indexed citations
11.
Wan, Junlai, et al.. (2022). Impact of treatment modalities on prognosis of patients with metastatic renal collecting duct carcinoma. Scientific Reports. 12(1). 12678–12678. 1 indexed citations
12.
Yuan, Xi, Junlai Wan, Long Huang, et al.. (2022). Thermosensitive hydrogel for cartilage regeneration via synergistic delivery of SDF-1α like polypeptides and kartogenin. Carbohydrate Polymers. 304. 120492–120492. 26 indexed citations
13.
Wan, Junlai, et al.. (2022). Epidemiological trends of hand osteoarthritis from 1990 to 2019: Estimates from the 2019 Global Burden of Disease study. Frontiers in Medicine. 9. 922321–922321. 22 indexed citations
14.
Wan, Junlai, et al.. (2022). Epidemiological Trends of Urolithiasis at the Global, Regional, and National Levels: A Population‐Based Study. International Journal of Clinical Practice. 2022(1). 6807203–6807203. 38 indexed citations
15.
Wan, Junlai, et al.. (2021). Clinicopathological Features and Prognostic Outcomes of Papillary Renal Cell Carcinoma. International Journal of General Medicine. Volume 14. 7523–7531. 4 indexed citations
16.
Lu, Rui, Xiaojun Yu, Shuang Liang, et al.. (2021). Physalin A Inhibits MAPK and NF-κB Signal Transduction Through Integrin αVβ3 and Exerts Chondroprotective Effect. Frontiers in Pharmacology. 12. 761922–761922. 15 indexed citations
17.
Wan, Junlai, et al.. (2015). Single-prolonged stress induce different change in the cell organelle of the hippocampal cells: A study of ultrastructure. Acta Histochemica. 118(1). 10–19. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026